 Significant Growth Reported in Total Revenue 127, Instrument Sales 178, and BaroFoldUST Services 298; Significant Decrease in Operating Loss 51 Achieved Investor Call Scheduled for Thursday, August 19, 2021 at 4:30 p.m. EDT SOUTH EASTON, MA ACCESSWIRE August 19, 2021 Pressure BioSciences, Inc. OTCQB:PBIO PBI or the Company, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food beverage industries, today reported continued strong financial results for the second quarter ended June 30, 2021, provided a business update, and offered guidance for the remainder of FY 2021. 